DLBDolby Laboratories, Inc.

$58.76-16% 1Y

Is the price fair?

Excellent

Undemanding: modest expectations priced in, cheap against its own history, and cheap vs its sector.

3 good
What the price assumes~−0% a yearderived · Jun 26, 2026

Priced for a decline (~−0% a year). The price bakes in little to no growth.

Vs its own P/E rangecheaper than 78% of its own historyderived

Cheap vs its own history: P/E 25.0 vs a 29.5 median over 41 quarters (−15% vs median).

Vs sector (EV/EBIT)16.1×derived · Sep 26, 2025

Sector median 23.3× across 246 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)middle of the market
FCF yieldbetter than 76% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What DLB's price assumes

Dolby Laboratories, Inc. trades at 25.0× earnings against 25.9× for the median Specialty Business Services name, cheaper than its own group.

25.0

Trailing P/E · Specialty Business Services median 25.9 · cheaper than the typical name in its group

Price / sales
3.68

Price / sales · today's price, fiscal year to Sep 26, 2025

Free cash flow yield
7.9%

Free cash flow yield · Specialty Business Services median 7.8%

Growth the price implies
−0.46%

Growth the price implies · The price pays for −0.46% free cash flow growth a year for a decade; the business has delivered +9.3% a year over the last three.

Details›
Price / booktoday's price, fiscal year to Sep 26, 2025
1.89
EV / EBITtoday's price, fiscal year to Sep 26, 2025
16.1
EV / salestoday's price, fiscal year to Sep 26, 2025
3.16
Industrials median P/E440 names
26.5
Specialty Business Services median P/E28 names
25.9
Free cash flow, trailing twelve months
$393M
Market capitalisation
$4.96B
3-year free cash flow growth
+9.3%
What the market has paid for these earnings: 41 quarters of its own multiple × $2.35 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$61.54
Its own P/E history, median$69.31
Its own P/E history, upper quartile$82.56
52-week range$48.51 – $71.44
Today$58.76

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.